Home/Cellino Biotech/Ed Tekeian

ET

Ed Tekeian

Chief Operating Officer

Cellino Biotech

Therapeutic Areas

Degenerative Diseases Metabolic Disorders Neurological Disorders Ophthalmology Renal Disease Cardiovascular Disease

Cellino Biotech Pipeline

Drug	Indication	Phase
Personalized Regenerative Therapies	Broad portfolio including Lung Disease, Macular Degeneration, Alzheimer’s, Parkinson’s, Diabetes, Kidney Disease, etc.	Pre-clinical/R&D

Leadership Team at Cellino Biotech

Dr. Marinna Madrid

Co-Founder, Chief Product and Regulatory Officer, Board Member

Deniz Aksel, PhD

Head of Bioengineering

View full Cellino Biotech profile